The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from vaccines that fight the virus at its point of attack – the nose and mouth. Most vaccines in human trials require two injections …
Read More »
NEW DELHI : Bharat Biotech International Ltd will use the adjuvant Alhydroxiquim-II to stimulate the immune response and provide longer-lasting immunity for its new coronavirus candidate vaccine, Covaxin, the company said in a statement Monday. The adjuvant is used under a license agreement signed with ViroVax LLC, based in the …
Read More »
Leading vaccine Bharat Biotech announced Monday that its Covaxin vaccine against coronavirus disease (Covid-19) will use the adjuvant Alhydroxiquim-II to stimulate the immune response. An adjuvant is a pharmacological or immunological agent that enhances the immune response of a vaccine by producing more antibodies and providing longer-lasting immunity. Kansas-based ViroVax …
Read More »
NEW DELHI: Bharat Biotech on Wednesday signed a licensing agreement with the Washington University School of Medicine in St Louis, USA, for a new intranasal single dose “chimpanzee adenovirus” vaccine for Covid-19. As Covid cases continue to show an increase around the world, several nations are working on vaccines that …
Read More »
Bharat Biotech, a leading vaccine and biotherapeutics manufacturer, has entered into a licensing agreement with Washington University School of Medicine in St. Louis, Missouri, USA, for a single-dose intranasal vaccine for coronavirus disease. (Covid-19). Bharat Biotech owns the rights to distribute the vaccine in all markets except the United States, …
Read More »
A vaccine for the coronavirus is likely to be ready in early 2021, but safely deploying it to India’s 1.3 billion people will be the country’s biggest challenge in fighting its growing epidemic, a leading vaccine scientist told Bloomberg. India, which is home to some of the cutting-edge vaccine clinical …
Read More »
The Indian Council for Medical Research (ICMR) said on Tuesday that three candidate vaccines against the coronavirus disease (Covid-19) are in the clinical stage of trials in India and one of them will soon begin Phase 3 trials after obtaining authorizations. The Covid-19 vaccine candidates made by Cadila Healthcare and …
Read More »
A woman dressed in white protective gear is in mourning after glimpsing the body of her husband, a Covid-19 victim, at a cremation site in Guwahati on September 10, 2020 (AP Photo / Anupam Nath). A total of 13,489 patients were discharged after treatment on the day, raising the number …
Read More »
COVAXIN: Bharat Biotech has published the results of a candidate vaccine administered to animals in trials New Delhi: Bharat Biotech, which is developing the COVAXIN coronavirus vaccine in its latest report, has said that an animal study has shown that a candidate vaccine has helped develop a strong immune response …
Read More »
NEW DELHI: Bharat Biotech International Limited has announced that its Covid-19 vaccine candidate, Covaxin, has shown positive efficacy in animal studies and has generated strong immune responses. Covaxin, developed by the Indian Council for Medical Research and Bharat Biotech, is being tested in 12 institutes in India. This indigenous vaccine …
Read More »